Chronic Spontaneous Urticaria Global Market Report 2025

Description

Chronic spontaneous urticaria (CSU) is a skin condition characterized by recurrent hives (raised, red, itchy welts) and angioedema (swelling) persisting for more than six weeks, without a clear external trigger. The exact cause of CSU is often unknown but may involve an autoimmune mechanism where the body's immune system erroneously targets healthy skin cells. Treatment primarily aims at managing symptoms, typically starting with antihistamines and, in more severe cases, other medications such as biologics.

The main treatments for chronic spontaneous urticaria include medication, phototherapy, and other interventions. Medication for CSU usually begins with antihistamines as the first-line approach, with options varying from non-sedating to sedating types based on the severity of symptoms and individual patient response. These medications can be administered orally, topically, parenterally, or through other routes. Diagnosis involves physical examination, blood tests, and allergy testing, and the treatments are utilized across various settings including hospitals, specialty clinics, home care settings, among others.

The chronic spontaneous urticaria research report is one of a series of new reports from The Business Research Company that provides chronic spontaneous urticaria market statistics, including the chronic spontaneous urticaria industry's global market size, regional shares, competitors with a chronic spontaneous urticaria market share, detailed chronic spontaneous urticaria market segments, market trends and opportunities, and any further data you may need to thrive in the chronic spontaneous urticaria industry. This chronic spontaneous urticaria market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic spontaneous urticaria market size has grown strongly in recent years. It will grow from $2.06 billion in 2024 to $2.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to improved diagnostic tools, growing awareness among healthcare, patient advocacy and support groups, ongoing studies and clinical trials exploring new therapies, and growing healthcare expenditure.

The chronic spontaneous urticaria market size is expected to see strong growth in the next few years. It will grow to $3.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to an increase in the number of diagnosed CSU cases, a growing patient pool, healthcare infrastructure development, favorable regulatory environment facilitating, patient-centric care models, and economic growth in emerging markets. Major trends in the forecast period include technology innovations, biological therapy advancements, personalized medicine, telemedicine and digital health, advanced diagnostic tools, AI and machine learning, and surging drug approvals and launches.

The anticipated rise in alcohol consumption is expected to drive growth in the chronic spontaneous urticaria market moving forward. Factors contributing to increased alcohol consumption include social norms, stress, advertising, affordability, and availability. For some individuals, alcohol consumption can exacerbate symptoms of chronic spontaneous urticaria, leading to heightened episodes of hives and swelling. For example, rehabs.UK reported in February 2024 that 55% of men and 41% of women in the UK consume alcohol weekly, with 8% of men and 5% of women reporting near-daily alcohol consumption. Between 2021 and 2022, there were 342,795 hospital admissions attributed solely to alcohol, resulting in a rate of 626 admissions per 100,000 people. Therefore, the increasing consumption of alcohol is a driving force behind the growth of the chronic spontaneous urticaria market.

Major companies in the chronic spontaneous urticaria market are advancing the development of next-generation Briquilimab (JSP191) to improve treatment efficacy and reduce dosing frequency. Briquilimab (JSP191) is a monoclonal antibody designed to target and deplete specific immune cells, particularly by targeting CD47, to treat conditions like chronic spontaneous urticaria. For example, in November 2023, Jasper Therapeutics Inc., a U.S.-based clinical-stage biotechnology company, announced it had dosed its first patient in a Phase 1b/2a clinical trial of Briquilimab for chronic spontaneous urticaria (CSU). This milestone is a significant step in evaluating the safety and effectiveness of Briquilimab, a next-generation monoclonal antibody targeting CD47, in treating this recurrent condition characterized by hives and itching. The study aims to determine how well Briquilimab can alleviate symptoms and improve the quality of life for patients suffering from CSU.

In March 2022, Novan Inc., a specialty dermatology company in the US, acquired EPI Health LLC to strengthen its commercial infrastructure in preparation for potential FDA approval of its lead product candidate, SB206 (berdazimer gel 10.3%), for molluscum contagiosum treatment. EPI Health LLC is known for providing Xyzal (levocetirizine) for managing uncomplicated skin manifestations.

Major companies operating in the chronic spontaneous urticaria market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Genentech Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Celltrion Inc., Allakos Inc., United BioPharma Inc.

North America was the largest region in the chronic spontaneous urticaria market in 2024. The regions covered in the chronic spontaneous urticaria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic spontaneous urticaria market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic spontaneous urticaria market consists of revenues earned by entities by providing services such as diagnostic services and medical consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic spontaneous urticaria market also includes sales of antihistamines, corticosteroids, and cyclosporine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Spontaneous Urticaria Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic spontaneous urticaria market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic spontaneous urticaria ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic spontaneous urticaria market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment: Medication; Phototherapy; Other Treatments
2) By Route Of Administration: Oral; Topical; Parenteral; Other Routes Of Administration
3) By Diagnosis: Physical Examination; Blood Test; Allergy Test; Other Diagnosis
4) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Medication: Antihistamines; Leukotriene Receptor Antagonists; Monoclonal Antibodies; Immunosuppressants; Corticosteroids (Oral and Topical)
2) By Phototherapy: UVB Phototherapy; UVA Phototherapy; Narrowband UVB Therapy
3) By Other Treatments: Alternative Therapies; Dietary Modifications; Psychotherapy (for Stress-Related Triggers)
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29786

1. Executive Summary

2. Chronic Spontaneous Urticaria Market Characteristics

3. Chronic Spontaneous Urticaria Market Trends And Strategies

4. Chronic Spontaneous Urticaria Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chronic Spontaneous Urticaria Growth Analysis And Strategic Analysis Framework

5.1. Global Chronic Spontaneous Urticaria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Chronic Spontaneous Urticaria Market Growth Rate Analysis
5.4. Global Chronic Spontaneous Urticaria Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Chronic Spontaneous Urticaria Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Chronic Spontaneous Urticaria Total Addressable Market (TAM)

6. Chronic Spontaneous Urticaria Market Segmentation

6.1. Global Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Phototherapy
Other Treatments
6.2. Global Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
Parenteral
Other Administrations
6.3. Global Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Physical Examination
Blood Test
Allergy Test
Other Diagnosis
6.4. Global Chronic Spontaneous Urticaria Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Homecare
Other End-Users
6.5. Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Leukotriene Receptor Antagonists
Monoclonal Antibodies
Immunosuppressants
Corticosteroids (Oral and Topical)
6.6. Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Phototherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
UVB Phototherapy
UVA Phototherapy
Narrowband UVB Therapy
6.7. Global Chronic Spontaneous Urticaria Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alternative Therapies
Dietary Modifications
Psychotherapy (for Stress-Related Triggers)

7. Chronic Spontaneous Urticaria Market Regional And Country Analysis

7.1. Global Chronic Spontaneous Urticaria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Chronic Spontaneous Urticaria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Spontaneous Urticaria Market

8.1. Asia-Pacific Chronic Spontaneous Urticaria Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Spontaneous Urticaria Market

9.1. China Chronic Spontaneous Urticaria Market Overview
9.2. China Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Spontaneous Urticaria Market

10.1. India Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Spontaneous Urticaria Market

11.1. Japan Chronic Spontaneous Urticaria Market Overview
11.2. Japan Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Spontaneous Urticaria Market

12.1. Australia Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Spontaneous Urticaria Market

13.1. Indonesia Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Spontaneous Urticaria Market

14.1. South Korea Chronic Spontaneous Urticaria Market Overview
14.2. South Korea Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Spontaneous Urticaria Market

15.1. Western Europe Chronic Spontaneous Urticaria Market Overview
15.2. Western Europe Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Spontaneous Urticaria Market

16.1. UK Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Spontaneous Urticaria Market

17.1. Germany Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Spontaneous Urticaria Market

18.1. France Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Spontaneous Urticaria Market

19.1. Italy Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Spontaneous Urticaria Market

20.1. Spain Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Spontaneous Urticaria Market

21.1. Eastern Europe Chronic Spontaneous Urticaria Market Overview
21.2. Eastern Europe Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Spontaneous Urticaria Market

22.1. Russia Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Spontaneous Urticaria Market

23.1. North America Chronic Spontaneous Urticaria Market Overview
23.2. North America Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Spontaneous Urticaria Market

24.1. USA Chronic Spontaneous Urticaria Market Overview
24.2. USA Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Spontaneous Urticaria Market

25.1. Canada Chronic Spontaneous Urticaria Market Overview
25.2. Canada Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Spontaneous Urticaria Market

26.1. South America Chronic Spontaneous Urticaria Market Overview
26.2. South America Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Spontaneous Urticaria Market

27.1. Brazil Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Spontaneous Urticaria Market

28.1. Middle East Chronic Spontaneous Urticaria Market Overview
28.2. Middle East Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Spontaneous Urticaria Market

29.1. Africa Chronic Spontaneous Urticaria Market Overview
29.2. Africa Chronic Spontaneous Urticaria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Chronic Spontaneous Urticaria Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Chronic Spontaneous Urticaria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Spontaneous Urticaria Market Competitive Landscape And Company Profiles

30.1. Chronic Spontaneous Urticaria Market Competitive Landscape
30.2. Chronic Spontaneous Urticaria Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Spontaneous Urticaria Market Other Major And Innovative Companies

31.1. AstraZeneca plc
31.2. Novartis AG
31.3. GlaxoSmithKline plc
31.4. Eli Lilly and Company
31.5. Amgen Inc.
31.6. Teva Pharmaceutical Industries Ltd.
31.7. Sun Pharmaceutical Industries Ltd.
31.8. Aurobindo Pharma Limited
31.9. Cipla Limited
31.10. Genentech Inc.
31.11. Dr. Reddy's Laboratories Ltd.
31.12. Hikma Pharmaceuticals plc
31.13. Celltrion Inc.
31.14. Allakos Inc.
31.15. United BioPharma Inc.

32. Global Chronic Spontaneous Urticaria Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Spontaneous Urticaria Market

34. Recent Developments In The Chronic Spontaneous Urticaria Market

35. Chronic Spontaneous Urticaria Market High Potential Countries, Segments and Strategies

35.1 Chronic Spontaneous Urticaria Market In 2029 - Countries Offering Most New Opportunities
35.2 Chronic Spontaneous Urticaria Market In 2029 - Segments Offering Most New Opportunities
35.3 Chronic Spontaneous Urticaria Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer